Recent Events Expanding Breast Cancer Treatment Options: A Q&A with BriaCell on their Cancer Immunotherapy and their Pipeline Posted on November 1, 2017March 14, 2019 by admin001 Expanding Breast Cancer Treatment Options: A Q&A with BriaCell on their Cancer Vaccine and their Pipeline FDA Approves the Roll-Over Combination Study with Checkpoint Inhibitor Immunotherapies to Allow Continued Access to their Immunotherapy in Patients with Advanced Breast Cancer BriaCell Provides Clinical Update
Skip to content
